DPI-221

DPI-221: DPI-221

Systematic (IUPAC) name

4-((αS)-α-((2S,5R)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide

Clinical data

Pregnancy cat. ?

Legal status ?

Identifiers

ATC code ?

PubChem CID 9891642

Chemical data

Formula C₂₁H₃₈F N₃O

Mol. mass 487.65 g/mol

SMILES eMolecules & PubChem

Y(what is this?) (verify)

DPI-221 is a drug which is used in scientific research. It is a highly selective agonist for the δ-opioid receptor which produces less convulsions than most drugs from this family.^[1]

References

^ Holt, JD; Watson, MJ; Chang, JP; O'Neill, SJ; Wei, K; Pendergast, W; Gengo, PJ; Chang, KJ (2005). "DPI-221 4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats". The Journal of pharmacology and experimental therapeutics 315 (2): 601–8. doi:10.1124/jpet.105.090498. PMID 16020629.

This analgesic-related article is a stub. You can help Wikipedia by expanding it.

Academic Dictionaries and Encyclopedias


Systematic (IUPAC) name
4-((αS)-α-((2S,5R)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide
Clinical data
Pregnancy cat.	?
Legal status	?
Identifiers
ATC code	?
PubChem	CID 9891642
Chemical data
Formula	C₂₁H₃₈F N₃O
Mol. mass	487.65 g/mol
SMILES	eMolecules & PubChem
Y(what is this?) (verify)